Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;11(9):1093-100.
doi: 10.1016/j.cgh.2013.04.044. Epub 2013 May 10.

Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review

Ravi N Sharaf  1 , Parvathi Myer, Christopher D Stave, Lisa C Diamond, Uri Ladabaum
Affiliations

Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review

Ravi N Sharaf et al. Clin Gastroenterol Hepatol. 2013 Sep.

Abstract

Background & aims: Screening of persons with newly diagnosed colorectal cancer for Lynch syndrome can yield substantial benefits at acceptable costs, presuming sufficient uptake of genetic testing by first-degree relatives of Lynch syndrome probands. We performed a systematic review of the literature to determine the frequency of and factors associated with genetic testing of first-degree relatives of Lynch syndrome probands.

Methods: We searched 4 databases (CINAHL, PsycInfo, PUBMED, and SCOPUS) for articles published through May 2011 reporting uptake of genetic testing by relatives of Lynch syndrome probands. Two investigators independently screened articles to determine whether they met inclusion criteria; data were collected on study population, genetic counseling, and genetic testing. A narrative, qualitative systematic review was performed.

Results: We identified 1258 potentially relevant articles; 533 underwent full-text review, and 8 were included in the final analysis. Of first-degree relatives of Lynch syndrome probands, 52% or less received genetic testing. For each proband, 3.6 or fewer relatives underwent genetic testing. Demographic factors (age <50 years, female sex, parenthood, level of education, employment, participation in medical studies), psychological factors (lack of depressive symptoms), and possibly family history (greater number of relatives with cancer) were associated with uptake of genetic testing.

Conclusions: Genetic testing appears to be underutilized by first-degree relatives of patients with Lynch syndrome. The clinical benefit and economic feasibility of screening persons with colorectal cancer for Lynch syndrome depend on optimizing family-wide uptake of genetic testing. Future research and clinical efforts should focus on ways to overcome barriers to genetic testing.

Keywords: CI; CRC; Colorectal Cancer; FDR; First-degree Relatives; GINA; Genetic Information Nondiscrimination Act; Genetic Testing; LS; Lynch Syndrome; Lynch syndrome; NOS; Newcastle–Ottawa Scale; OR; Second-degree Relative; colorectal cancer; confidence interval; first-degree relative; odds ratio.

PubMed Disclaimer

Conflict of interest statement

Disclosures: None to report. No conflicts of interest exist.

Figures

Figure 1:
Figure 1:
Literature Search and Study Selection
See this image and copyright information in PMC

Comment in

References

    1. Burt R, Barthel J, Dunn K, David D, Drelichman E, Ford J, Giardiello F, Gruber S, Halverson A, Hamilton S, Ismail M, Jasperson K, Lazenby A, Lynch P, Martin E Jr, Mayer R, Ness R, Provenzale D, Rao M, Shike M, Steinbach G, Terdiman J, Weinberg D. Colorectal cancer screening: Clinical practice guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network 2010;8:8–60. - PubMed
    1. Group EW. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 2009;11:35–41. - PMC - PubMed
    1. Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Annals of internal medicine 2011;155:69–79. - PMC - PubMed
    1. Palomaki G, McClain M, Melillo S, Hampel H, Thibodeau S. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genetics in Medicine 2009;11:42–65. - PMC - PubMed
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264–9, W64. - PubMed

Publication types

MeSH terms